Top Clinical Trials companies in the world by Inventory

This ranking features the top 278 Clinical Trials companies in the world ranked by Inventory, totalling a Inventory of USD 3.48 B, for January 15, 2025.

Global

Clinical Trials

#	Name	Inventory	Reported Date	Stock Price	Change	Country
1	Vertex Pharmaceuticals Incorporated 1 VRTX	USD 738.80 M	Dec. 31, 2023	USD 411.66	-0.41%	United States
2	BioNTech SE 2 22UA.F	USD 394.81 M	Dec. 31, 2023	USD 116.36	-0.45%	Germany
3	Charles River Laboratories International, Inc. 3 CRL	USD 380.26 M	Dec. 30, 2023	USD 178.08	-6.34%	United States
4	Sarepta Therapeutics, Inc. 4 SRPT	USD 322.86 M	Dec. 31, 2023	USD 118.83	0.34%	United States
5	Joinn Laboratories(China)Co.,Ltd. 5 6127.HK	USD 262.42 M	Dec. 31, 2023	USD 1.06	2.98%	China
6	Shanghai Henlius Biotech, Inc. 6 2696.HK	USD 106.67 M	Dec. 31, 2023	USD 2.59	-10.24%	China
7	RemeGen Co., Ltd. 7 9995.HK	USD 104.45 M	Dec. 31, 2023	USD 1.59	2.46%	China
8	Alnylam Pharmaceuticals, Inc. 8 ALNY	USD 89.15 M	Dec. 31, 2023	USD 240.51	-6.88%	United States
9	Shin Nippon Biomedical Laboratories, Ltd. 9 2395.T	USD 81.75 M	March 31, 2024	USD 10.78	1.91%	Japan
10	Supernus Pharmaceuticals, Inc. 10 SUPN	USD 77.41 M	Dec. 31, 2023	USD 37.82	0.66%	United States
11	Incyte Corporation 11 INCY	USD 62.97 M	Dec. 31, 2023	USD 71.93	-0.61%	United States
12	Guardant Health, Inc. 12 GH	USD 61.95 M	Dec. 31, 2023	USD 37.46	-1.68%	United States
13	Akeso, Inc. 13 9926.HK	USD 55.19 M	Dec. 31, 2023	USD 7.28	2.32%	China
14	HUTCHMED (China) Limited 14 0013.HK	USD 50.26 M	Dec. 31, 2023	USD 3.02	2.59%	Hong Kong
15	Zai Lab Limited 15 9688.HK	USD 44.83 M	Dec. 31, 2023	USD 2.49	0.18%	China
16	TaiMed Biologics Inc. 16 4147.TWO	USD 41.39 M	Dec. 31, 2023	USD 2.64	-2.78%	Taiwan
17	TG Therapeutics, Inc. 17 TGTX	USD 39.82 M	Dec. 31, 2023	USD 29.74	7.48%	United States
18	Xeris Biopharma Holdings, Inc. 18 XERS	USD 38.84 M	Dec. 31, 2023	USD 3.20	-2.44%	United States
19	Neurocrine Biosciences, Inc. 19 NBIX	USD 38.30 M	Dec. 31, 2023	USD 139.51	-2.46%	United States
20	CureVac N.V. 20 5CV.F	USD 27.37 M	Dec. 31, 2023	USD 3.95	-0.95%	Germany
21	NeoGenomics, Inc. 21 NEO	USD 24.16 M	Dec. 31, 2023	USD 13.78	9.11%	United States
22	Mirum Pharmaceuticals, Inc. 22 MIRM	USD 22.31 M	Dec. 31, 2023	USD 43.32	-1.54%	United States
23	Blueprint Medicines Corporation 23 BPMC	USD 21.22 M	Dec. 31, 2023	USD 102.56	-0.77%	United States
24	Legend Biotech Corporation 24 LEGN	USD 19.43 M	Dec. 31, 2023	USD 31.64	-2.65%	United States
25	TOT BIOPHARM International Company Limited 25 1875.HK	USD 17.75 M	Dec. 31, 2023	USD 0.24	4.98%	China
26	Exelixis, Inc. 26 EXEL	USD 17.32 M	Dec. 29, 2023	USD 35.65	0.99%	United States
27	InnoCare Pharma Limited 27 9969.HK	USD 16.77 M	Dec. 31, 2023	USD 0.69	3.45%	China
28	GNI Group Ltd. 28 2160.T	USD 16.52 M	Dec. 31, 2023	USD 19.77	1.11%	Japan
29	ADC Therapeutics SA 29 ADCT	USD 16.18 M	Dec. 31, 2023	USD 1.71	-0.58%	Switzerland
30	Axsome Therapeutics, Inc. 30 AXSM	USD 15.13 M	Dec. 31, 2023	USD 84.60	-5.23%	United States
31	Adaptive Biotechnologies Corporation 31 ADPT	USD 14.45 M	Dec. 31, 2023	USD 6.07	-6.04%	United States
32	InflaRx N.V. 32 IFRX	USD 12.55 M	Dec. 31, 2023	USD 2.34	NA	Germany
33	uniQure N.V. 33 QURE	USD 12.02 M	Dec. 31, 2023	USD 13.23	-4.06%	Netherlands
34	Telix Pharmaceuticals Limited 34 TLX.AX	USD 11.79 M	Dec. 31, 2023	USD 15.47	4.25%	Australia
35	Intra-Cellular Therapies, Inc. 35 ITCI	USD 11.65 M	Dec. 31, 2023	USD 126.89	-0.24%	United States
36	GeneOne Life Science, Inc. 36 011000.KS	USD 11.44 M	Dec. 31, 2023	USD 1.67	-1.86%	South Korea
37	Australian Clinical Labs Limited 37 ACL.AX	USD 11.22 M	June 30, 2024	USD 2.14	0.82%	Australia
38	Alphamab Oncology 38 9966.HK	USD 11.09 M	Dec. 31, 2023	USD 0.43	4.62%	China
39	ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 39 1541.HK	USD 10.81 M	Dec. 31, 2023	USD 0.62	4.32%	China
40	Burning Rock Biotech Limited 40 BNR	USD 9.72 M	Dec. 31, 2023	USD 6.55	-6.69%	China
41	Atara Biotherapeutics, Inc. 41 ATRA	USD 9.71 M	Dec. 31, 2023	USD 12.31	-23.96%	United States
42	Hua Medicine (Shanghai) Ltd. 42 2552.HK	USD 9.56 M	Dec. 31, 2023	USD 0.17	-0.02%	China
43	Travere Therapeutics, Inc. 43 TVTX	USD 9.41 M	Dec. 31, 2023	USD 17.07	-8.18%	United States
44	Keymed Biosciences Inc. 44 2162.HK	USD 8.61 M	Dec. 31, 2023	USD 3.69	1.93%	China
45	Genmab A/S 45 GMAB.CO	USD 8.44 M	Dec. 31, 2023	USD 216.88	1.28%	Denmark
46	Castle Biosciences, Inc. 46 CSTL	USD 7.94 M	Dec. 31, 2023	USD 25.46	-2.64%	United States
47	Corcept Therapeutics Incorporated 47 CORT	USD 7.73 M	Dec. 31, 2023	USD 51.66	1.18%	United States
48	Krystal Biotech, Inc. 48 KRYS	USD 6.99 M	Dec. 31, 2023	USD 142.64	-5.10%	United States
49	Kindstar Globalgene Technology, Inc. 49 9960.HK	USD 6.86 M	Dec. 31, 2023	USD 0.15	-0.02%	China
50	Microbio Co., Ltd. 50 4128.TWO	USD 6.47 M	Dec. 31, 2023	USD 0.93	4.52%	Taiwan

1 2 3 4 5 6

Frequently Asked Questions

Which Clinical Trials company has the highest Inventory ?

The Clinical Trials company with the highest Inventory is Vertex Pharmaceuticals Incorporated (NasdaqGS: VRTX) at USD 738.80 M.
Which Clinical Trials company has the lowest Inventory ?

The Clinical Trials company with the lowest Inventory is Silence Therapeutics plc (NasdaqGM: SLN) at USD -23.67 M.

What are the top 10 Clinical Trials companies by Inventory ?

The top 10 Clinical Trials companies the Global by Inventory are Vertex Pharmaceuticals Incorporated, BioNTech SE, Charles River Laboratories International, Inc., Sarepta Therapeutics, Inc., Joinn Laboratories(China)Co.,Ltd., Shanghai Henlius Biotech, Inc., RemeGen Co., Ltd., Alnylam Pharmaceuticals, Inc., Shin Nippon Biomedical Laboratories, Ltd. and Supernus Pharmaceuticals, Inc..
What are the bottom 10 Clinical Trials companies by Inventory ?

The bottom 10 Clinical Trials companies by Inventory are Silence Therapeutics plc, Biohaven Pharmaceutical Holding Company Ltd., BioArctic AB (publ), Alpha Tau Medical Ltd., Vivoryon Therapeutics N.V., ABIVAX Société Anonyme, MedPacto, Inc., SanBio Company Limited, XORTX Therapeutics Inc. and Xencor, Inc..